Health Condition 1: F330- Major depressive disorder, recurrent, mild Health Condition 2: F419- Anxiety disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are positive on DASS 21 scale (mild depression, mild anxiety and mild stress) Patients who have any systemic illness as comorbidity. (they will be continuing the medications for the same)
Exclusion criteria
Exclusion criteria: Cognitive impairment Patients who has score less than 24 in MMSE Patients who are taking allopathic medications for any Psychiatric illness Concurrent participation in other clinical trials involving interventions for anxiety, depression or stress Those who are positive on DASS 21 but in moderate and severe categories of depression, anxiety and stress.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in total score of the Successful Aging Inventory (SAI) following individualized homoeopathic treatmentTimepoint: Screening and pre intervention assessments 3 months Intervention and post intervention assessments 12 months Data analysis and interpretation of the results 3 months Total duration 1 year 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in domain-wise scores of the Successful Aging Inventory (SAI), including: Functional Performance Mechanisms Intrapsychic Factors Spirituality GerotranscendenceTimepoint: Screening and pre intervention assessments 3 months Intervention and post intervention assessments 12 months ;Change in Depression, Anxiety, and Stress levels as measured by the Depression Anxiety Stress Scales 21 (DASS-21)Timepoint: Screening and pre intervention assessments 3 months Intervention and post intervention assessments 12 months | — |
Countries
India
Contacts
MLDawale Memorial Homoeopathic Institute